Below is a current listing of Mirati’s collaborative clinical trials. Click on a clinical trial to learn more.
BeiGene Sponsored Trials
Study BGB-900-103 - Phase 1b study of sitravatinib in combination for advanced solid tumors
A Phase 1b study to assess sitravatinib in combination with tisleizumab in patients with advanced solid tumors
Study BGB-900-104 - Phase 1/2 study of sitravatinib monotherapy and in combination for HCC or GC/GEJC
A Phase 1/2 study to investigate sitravatinib as a monotherapy and in combination with tislelizumab in patients with unresectable locally advanced or metastatic HCC or GC/GEJC
To identify clinical trials that match your diagnosis, treatment history and location, call 1-844-893-5530 or use our online Study Locator